Darren S. Cline - Mar 6, 2023 Form 4 Insider Report for PLIANT THERAPEUTICS, INC. (PLRX)

Role
Director
Signature
/s/Mike Ouimette, attorney-in-fact
Stock symbol
PLRX
Transactions as of
Mar 6, 2023
Transactions value $
$0
Form type
4
Date filed
3/8/2023, 03:36 PM
Previous filing
Apr 4, 2022
Next filing
Mar 28, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PLRX Stock Option (Right to Buy) Award $0 +22K $0.00 22K Mar 6, 2023 Common Stock 22K $31.11 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 1/36th of the shares subject to such option vest and become exercisable in substantially equal installments on each monthly anniversary of March 6, 2023, subject to the Reporting Person's continuous service to the Issuer on each such date.